BACK TO FAESFARMA.COM 
General Information
Other Relevant Information
| Type | |
|---|---|
| Statement 01/07/2025. Certification of new pharmaceutical plant in Derio (Bizkaia). |
Download
|
| Type | |
|---|---|
| Statement 11/29/2024. Interim dividend 2024. |
Download
|
| Statement 10/31/2024. January- September 2024 results. |
Download
|
| Statement 07/30/2024. Business report first half 2024. |
Download
|
| Statement 06/25/2024. Relevant aspects of the Shareholders' Meeting. |
Download
|
| Statement 06/25/2024. Change of presidency of the Audit and Compliance Committee. |
Download
|
| Statement 06/25/2024. Payment of complementary dividend for 2023. |
Download
|
| Statement 05/02/2024. Proposal for the appointment of a CEO. |
Download
|
| Statement 04/26/2024. January-March 2024 results. |
Download
|
| Type | |
|---|---|
| Statement 11/30/2023. Interim dividend 2023. |
Download
|
| Statement 10/25/2023. January- September 2023 results. |
Download
|
| Statement 06/27/2023. News about bilastine. |
Download
|
| Statement 05/04/2023. Acquisition Novosci. |
Download
|
| Statement 04/26/2023. January-March 2023 results. |
Download
|
| Statement 03/29/2023. Capital Markets Day presentation. |
Download
|
| Statement 03/27/2023. Approval of the scrip dividend. |
Download
|
| Statement 02/28/2023. Business update information 2022. |
Download
|
| Type | |
|---|---|
| Statement 12/22/2022. Appointments of Commissions. |
Download
|
| Statement 10/27/2022. January- September 2022 results. |
Download
|
| Statement 07/28/2022. January-June 2022 results. |
Download
|
| Statement 04/29/2022. January-March 2022 results. |
Download
|
| Statement 03/22/2022. Capital Market presentation. |
Download
|
| Statement 02/25/2022. January-December results. |
Download
|
